Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
Related structures:
AlphaFold database: Q4Q9I2
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 4 |
GO:0004175 | endopeptidase activity | 4 | 3 |
GO:0004252 | serine-type endopeptidase activity | 5 | 3 |
GO:0008233 | peptidase activity | 3 | 4 |
GO:0008236 | serine-type peptidase activity | 4 | 3 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0017171 | serine hydrolase activity | 3 | 3 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.438 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.649 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.365 |
CLV_PCSK_KEX2_1 | 170 | 172 | PF00082 | 0.400 |
CLV_PCSK_PC1ET2_1 | 142 | 144 | PF00082 | 0.376 |
CLV_PCSK_PC7_1 | 166 | 172 | PF00082 | 0.493 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.660 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.531 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.609 |
DOC_MAPK_gen_1 | 170 | 178 | PF00069 | 0.580 |
DOC_MAPK_MEF2A_6 | 81 | 88 | PF00069 | 0.311 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.624 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.629 |
LIG_14-3-3_CanoR_1 | 40 | 48 | PF00244 | 0.386 |
LIG_Actin_WH2_2 | 126 | 144 | PF00022 | 0.622 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.441 |
LIG_BRCT_BRCA1_1 | 193 | 197 | PF00533 | 0.420 |
LIG_BRCT_BRCA1_1 | 40 | 44 | PF00533 | 0.387 |
LIG_eIF4E_1 | 126 | 132 | PF01652 | 0.593 |
LIG_eIF4E_1 | 162 | 168 | PF01652 | 0.651 |
LIG_eIF4E_1 | 87 | 93 | PF01652 | 0.414 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.546 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.401 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.407 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.380 |
LIG_FHA_2 | 156 | 162 | PF00498 | 0.573 |
LIG_FHA_2 | 198 | 204 | PF00498 | 0.375 |
LIG_LIR_Apic_2 | 160 | 165 | PF02991 | 0.539 |
LIG_LIR_Apic_2 | 42 | 48 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 190 | 198 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 158 | 162 | PF02991 | 0.594 |
LIG_LIR_Nem_3 | 190 | 196 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 94 | 99 | PF02991 | 0.337 |
LIG_MLH1_MIPbox_1 | 194 | 198 | PF16413 | 0.443 |
LIG_Pex14_2 | 96 | 100 | PF04695 | 0.337 |
LIG_PTB_Apo_2 | 177 | 184 | PF02174 | 0.488 |
LIG_REV1ctd_RIR_1 | 195 | 205 | PF16727 | 0.579 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.579 |
LIG_SH2_CRK | 193 | 197 | PF00017 | 0.411 |
LIG_SH2_PTP2 | 162 | 165 | PF00017 | 0.555 |
LIG_SH2_STAP1 | 159 | 163 | PF00017 | 0.542 |
LIG_SH2_STAP1 | 193 | 197 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.547 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.277 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.392 |
LIG_SUMO_SIM_anti_2 | 128 | 133 | PF11976 | 0.553 |
LIG_SUMO_SIM_par_1 | 21 | 28 | PF11976 | 0.397 |
LIG_TYR_ITIM | 191 | 196 | PF00017 | 0.451 |
LIG_WRC_WIRS_1 | 93 | 98 | PF05994 | 0.328 |
LIG_WW_3 | 214 | 218 | PF00397 | 0.464 |
MOD_CDK_SPK_2 | 161 | 166 | PF00069 | 0.541 |
MOD_CK2_1 | 155 | 161 | PF00069 | 0.461 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.453 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.540 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.524 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.393 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.435 |
MOD_N-GLC_1 | 55 | 60 | PF02516 | 0.524 |
MOD_NEK2_1 | 12 | 17 | PF00069 | 0.515 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.324 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.467 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.445 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.405 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.388 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.343 |
MOD_PIKK_1 | 108 | 114 | PF00454 | 0.489 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.550 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.497 |
MOD_Plk_1 | 202 | 208 | PF00069 | 0.505 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.535 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.403 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.328 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.430 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.553 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.411 |
TRG_ER_diArg_1 | 170 | 172 | PF00400 | 0.623 |
TRG_ER_diArg_1 | 198 | 201 | PF00400 | 0.504 |
TRG_Pf-PMV_PEXEL_1 | 72 | 76 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3Z5 | Leptomonas seymouri | 78% | 93% |
A0A0S4INS6 | Bodo saltans | 45% | 99% |
A0A1X0NU17 | Trypanosomatidae | 60% | 95% |
A0A3Q8IDK2 | Leishmania donovani | 97% | 94% |
A0A422N342 | Trypanosoma rangeli | 61% | 95% |
A4HEL7 | Leishmania braziliensis | 86% | 94% |
A4I1V0 | Leishmania infantum | 97% | 94% |
C9ZS72 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 94% |
E9AXZ3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 94% |
Q4Q9H9 | Leishmania major | 100% | 100% |
V5B9I6 | Trypanosoma cruzi | 61% | 95% |